Determinants of hospital length of stay for schizophrenia: retrospective negative binomial analysis in a university hospital
BJPsych Open · 2026-03 · 12 (2)
DOI: 10.1192/bjo.2025.10973 ↗Kurz gefasst
Fachartikel in der Zeitschrift BJPsych Open, online erschienen am 10.03.2026. Verfasst von Răzvan Pop und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Informatics and Biostatistics, Faculty of Medicine, Iuliu Hațieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-SA 4.0).
Abstract (Originalsprache)
Background
Limited data exist on factors influencing the length of hospital stay (HLoS) in patients with schizophrenia.
Aims
This study aimed to identify and quantify patient characteristics associated with HLoS.
Method
A retrospective study was conducted on patients diagnosed with schizophrenia (F20, ICD-10) admitted to the County Emergency Hospital of Cluj-Napoca, Romania, from 2018 to 2022. Demographics, comorbidities, symptom severity (Positive and Negative Syndrome Scale/Brief Psychiatric Rating Scale), antipsychotic treatment and adverse effects data were collected from medical charts. Predictors of HLoS for patients with one hospitalisation were assessed using negative binomial regression.
Results
The sample comprised 288 patients aged 18–65 years, with 75% over 30 years and a balanced gender distribution. Most patients had no comorbidities (64.24%) whereas 49.46% reported addictions. Men had higher rates of tobacco use (62.00 v . 53.49%) and self-reported use of substances/drugs (15.49 v . 3.91%). Independent predictors of HLoS ( P < 0.05) in the multivariable model included gender, being retired, experiencing fear or violence in the context of psychotic decompensation, percentage score reduction in symptom severity score, first-generation antipsychotics treatment and the presence of reasons for late discharge. Men had an expected HLoS 39% longer than women. Experiencing fear (adjusted incidence rate ratio (aIRR) 1.13, 95% CI [1.01; 1.27]) and violence in the context of psychotic decompensation (aIRR 1.19, 95% CI [1.06; 1.34]), and first-generation antipsychotics treatment (aIRR 1.17, 95% CI [1.02; 1.35]) were associated with longer stay, whereas being retired predicted shorter HLoS (aIRR 0.83, 95% CI [0.70; 0.98]).
Conclusions
The length of hospital stay in patients with schizophrenia is influenced by demographic, clinical and treatment factors. Targeted interventions addressing these predictors may optimise the duration of hospitalisation.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medical Informatics and Biostatistics, Faculty of Medicine, Iuliu Hațieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania.
- Department of Medical Informatics and Biostatistics, Faculty of Nursing and Health Science, https://ror.org/051h0cw83Iuliu Hațieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania.
- Department of Neurosciences, Faculty of Medicine, Iuliu Hațieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania.
ORCID-Profile: Sorana D Bolboacă
Zitieren
APA
Pop, R., Iancu, M., Micluția, I. V., Crișan, C. A., Pop, E., & Bolboacă, S. D. (2026). Determinants of hospital length of stay for schizophrenia: retrospective negative binomial analysis in a university hospital. BJPsych Open, 12(2). https://doi.org/10.1192/bjo.2025.10973
Vancouver
Pop R, Iancu M, Micluția IV, Crișan CA, Pop E, Bolboacă SD. Determinants of hospital length of stay for schizophrenia: retrospective negative binomial analysis in a university hospital. BJPsych Open. 2026;12(2). doi:10.1192/bjo.2025.10973
BibTeX
@article{Pop2026,
author = {Pop, Răzvan and Iancu, Mihaela and Micluția, Ioana Valentina and Crișan, Cătălina Angela and Pop, Emilia and Bolboacă, Sorana D},
title = {Determinants of hospital length of stay for schizophrenia: retrospective negative binomial analysis in a university hospital},
journal = {BJPsych Open},
year = {2026},
volume = {12},
number = {2},
doi = {10.1192/bjo.2025.10973}
}
EUVIMED